Clinical Trials on 血容量扩张 in Australia
总计4102个结果
-
Croma-Pharma GmbHFGK Clinical Research GmbH完全的
-
Croma-Pharma GmbHProinnovera GmbH完全的
-
Kepler University HospitalMedtronic完全的
-
AO Innovation Translation CenterAO Foundation, AO Spine招聘中
-
ModernaTX, Inc.AstraZeneca主动,不招人剂量递增:复发/难治性实体瘤恶性肿瘤或淋巴瘤 | 剂量扩展:三阴性乳腺癌、HNSCC、非霍奇金癌、尿路上皮癌、免疫检查点难治性黑色素瘤和 NSCLC 淋巴瘤美国, 以色列, 澳大利亚
-
Pulmonx International Sàrl完全的
-
Eli Lilly and Company完全的
-
Kirby InstituteBristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer Ingelheim 和其他合作者完全的
-
eXIthera PharmaceuticalsSyneos Health; CPR Pharma Services Pty Ltd, Australia; IDT CMAX Clinical Trials完全的
-
Celgene Corporation完全的
-
ADARx Pharmaceuticals, Inc.ADARx Australia Pty Ltd招聘中
-
PfizerHospira, now a wholly owned subsidiary of Pfizer完全的
-
Foundation for Cardiovascular Research, ZurichAbbott Medical Devices未知
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma Group完全的
-
Novartis Pharmaceuticals终止
-
Monash UniversityCurtin University; Flinders University; Ambulance Victoria; SA Ambulance Service完全的
-
Australian and New Zealand Intensive Care Research...Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian College... 和其他合作者招聘中
-
Royal Perth HospitalThe University of Western Australia招聘中
-
South Australian Health and Medical Research InstituteFlinders University完全的
-
InfraredxRoyal Adelaide Hospital; South Australian Health and Medical Research Institute完全的
-
Boston Scientific Corporation完全的